ZA874636B - 2-(aminoalkylthio)methyl-1,4-dihydropyridine,a method for the preparation thereof and pharmaceutical compositions containing them - Google Patents

2-(aminoalkylthio)methyl-1,4-dihydropyridine,a method for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
ZA874636B
ZA874636B ZA874636A ZA874636A ZA874636B ZA 874636 B ZA874636 B ZA 874636B ZA 874636 A ZA874636 A ZA 874636A ZA 874636 A ZA874636 A ZA 874636A ZA 874636 B ZA874636 B ZA 874636B
Authority
ZA
South Africa
Prior art keywords
aminoalkylthio
dihydropyridine
methyl
preparation
pharmaceutical compositions
Prior art date
Application number
ZA874636A
Other languages
English (en)
Inventor
Carmelo A Gandolfi
A Gandolfi Carmelo
Marco Frigerio
Frigerio Marco
Silvano Spinelli
Spinelli Silvano
Odoardo Tofanetti
Tofanetti Odoardo
Sergio Tognella
Tognella Sergio
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Publication of ZA874636B publication Critical patent/ZA874636B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA874636A 1986-06-27 1987-06-26 2-(aminoalkylthio)methyl-1,4-dihydropyridine,a method for the preparation thereof and pharmaceutical compositions containing them ZA874636B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20965/86A IT1204421B (it) 1986-06-27 1986-06-27 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono

Publications (1)

Publication Number Publication Date
ZA874636B true ZA874636B (en) 1988-03-30

Family

ID=11174716

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874636A ZA874636B (en) 1986-06-27 1987-06-26 2-(aminoalkylthio)methyl-1,4-dihydropyridine,a method for the preparation thereof and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US5047414A (it)
EP (2) EP0254064B1 (it)
JP (1) JPH0832686B2 (it)
KR (1) KR950002154B1 (it)
AU (1) AU603595B2 (it)
CA (1) CA1322753C (it)
DK (1) DK164051C (it)
ES (1) ES2037029T3 (it)
FI (1) FI91149C (it)
GR (1) GR3004954T3 (it)
HU (1) HU201305B (it)
IT (1) IT1204421B (it)
MX (1) MX7134A (it)
NZ (1) NZ220868A (it)
PH (1) PH23208A (it)
PL (1) PL156170B1 (it)
RU (1) RU1816282C (it)
WO (1) WO1988000187A1 (it)
ZA (1) ZA874636B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
PL140069B1 (en) * 1982-12-21 1987-03-31 Pfizer Method of obtaining new derivatives of dihydropiridine
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
GR851819B (it) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
FI885930A (fi) 1988-12-21
EP0254064B1 (en) 1992-06-17
DK99588D0 (da) 1988-02-25
DK164051C (da) 1992-09-28
CA1322753C (en) 1993-10-05
EP0312541B1 (en) 1992-08-26
KR880701228A (ko) 1988-07-26
DK99588A (da) 1988-02-25
PH23208A (en) 1989-06-06
KR950002154B1 (ko) 1995-03-14
WO1988000187A1 (en) 1988-01-14
US5047414A (en) 1991-09-10
MX7134A (es) 1993-10-01
HUT49572A (en) 1989-10-30
IT8620965A0 (it) 1986-06-27
EP0312541A1 (en) 1989-04-26
JPH01503065A (ja) 1989-10-19
NZ220868A (en) 1989-10-27
HU201305B (en) 1990-10-28
PL266481A1 (en) 1988-09-01
FI91149C (fi) 1994-05-25
PL156170B1 (pl) 1992-02-28
ES2037029T3 (es) 1993-06-16
AU7696987A (en) 1988-01-29
FI91149B (fi) 1994-02-15
EP0254064A1 (en) 1988-01-27
JPH0832686B2 (ja) 1996-03-29
GR3004954T3 (it) 1993-04-28
AU603595B2 (en) 1990-11-22
IT1204421B (it) 1989-03-01
DK164051B (da) 1992-05-04
RU1816282C (ru) 1993-05-15

Similar Documents

Publication Publication Date Title
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
EP0655459A3 (en) Process for the preparation of the 1,2-double bond of 4-aza steroids and crystalline Proscor (R) and pharmaceutical preparations thereof.
IL81950A0 (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof processes for the preparation thereof and pharmaceutical compositions containing them
ZA877414B (en) New imidazo-benzoxazinones,the preparation thereof and pharmaceutical compositions containing these compounds
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA89958B (en) Pharmaceutical compositions containing lactams,new substituted lactams and processes for the preparation thereof
AU8245087A (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
IL80339A (en) 2-(2-(2-pyridyl)- phenylsulphinyl) -benzimidazoles, their preparation and pharmaceutical compositions containing them
PH24599A (en) Amonoycyllabdanes, pharmaceutical compositions and a process for the preparations thereof
IL91675A0 (en) Cyclic compounds,pharmaceutical compositions containing the same and processes for the preparation thereof
EP0430025A3 (en) Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
IL84955A0 (en) Novel carbamoyloxylabdanes,process for the preparation thereof and pharmaceutical compositions containing them
IL81949A0 (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof,processes for their preparation and pharmaceutical compositions containing them
IL82294A (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA874636B (en) 2-(aminoalkylthio)methyl-1,4-dihydropyridine,a method for the preparation thereof and pharmaceutical compositions containing them
GB2190678B (en) 3-(hydroxymethyl)-isoquinoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
DE3264768D1 (en) Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same
ZA908298B (en) Optically active thiazetoquinoline-3-carboxylic acid compound,method for preparation thereof,and a pharmaceutical composition comprising the same
AU1153088A (en) New aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them
ZA853375B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
IL85162A0 (en) 3-methylenespiro(benzofuranpiperidines),a process for the preparation thereof,and pharmaceutical compositions containing them
ZA904665B (en) Piperidine derivative,method for preparation thereof,and a pharmaceutical composition comprising the same
ZA93813B (en) 1,4-dihydropyridine compounds, a process for their preparation and pharmaceutical compositions containing them.
IL91315A0 (en) 2,3,4,5-tetrahydro-1-benzoxepins,a process for the preparation thereof and pharmaceutical compositions based on these compounds